80 FR 15798 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 57 (March 25, 2015)

Page Range		15798-15798
FR Document		2015-06849

Federal Register, Volume 80 Issue 57 (Wednesday, March 25, 2015)

[Federal Register Volume 80, Number 57 (Wednesday, March 25, 2015)]
[Notices]
[Page 15798]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06849]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Using Longitudinal Data to 
Characterize the Natural History of Fragile X Syndrome to Improve 
Services and Outcomes, DD15-003, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 10:00 a.m.-6:00 p.m., April 14, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Using Longitudinal Data to Characterize the Natural 
History of Fragile X Syndrome to Improve Services and Outcomes, 
DD15-003, initial review.''
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office Centers for 
Disease Control and Prevention.
[FR Doc. 2015-06849 Filed 3-24-15; 8:45 am]
 BILLING CODE 4163-18-P

15798 Federal Register / Vol. 80, No. 57 / Wednesday, March 25, 2015 / Notices

startres.aspx?EICode=3132& (Catalogue of Federal Domestic Assistance DEPARTMENT OF HEALTH AND
Attcode=72. Program Nos. 93.853, Clinical Research HUMAN SERVICES
The Marriott Bethesda North Hotel Related to Neurological Disorders; 93.854,
and Conference Center has a limited Biological Basis Research in the National Institutes of Health
number of rooms available at the Neurosciences, National Institutes of Health,
HHS) National Institute of Allergy and
discounted rate of $199 per night until
April 3, 2015, or until the block is filled. Dated: March 19, 2015.
Infectious Diseases; Notice of Closed
To receive this rate, attendees are asked Meetings
Carolyn Baum,
to make reservations using the link to Pursuant to section 10(d) of the
Program Analyst, Office of Federal Advisory
the hotel reservation page or by calling Committee Policy. Federal Advisory Committee Act, as
855–355–0302 or 212–532–1660. If amended (5 U.S.C. App.), notice is
[FR Doc. 2015–06841 Filed 3–24–15; 8:45 am]
calling, please select the first option for hereby given of the following meetings.
BILLING CODE 4140–01–P
‘‘Hotel Reservations’’ and inform the The meetings will be closed to the
phone agent that you are making a public in accordance with the
reservation for ‘‘Event #15008’’. provisions set forth in sections
If you need special accommodations DEPARTMENT OF HEALTH AND
HUMAN SERVICES 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
because of disability, please contact as amended. The grant applications and
Ellen.Diegel@diahome.org at least 7 Centers for Disease Control and the discussions could disclose
days before the meeting. Prevention confidential trade secrets or commercial
Dated: March 19, 2015. property such as patentable material,
Leslie Kux, Disease, Disability, and Injury and personal information concerning
Associate Commissioner for Policy. Prevention and Control Special individuals associated with the grant
[FR Doc. 2015–06702 Filed 3–24–15; 8:45 am]
Emphasis Panel (SEP): Initial Review applications, the disclosure of which
BILLING CODE 4164–01–P would constitute a clearly unwarranted
The meeting announced below invasion of personal privacy.
concerns Using Longitudinal Data to
Characterize the Natural History of Name of Committee: National Institute of
DEPARTMENT OF HEALTH AND Allergy and Infectious Diseases, Special
HUMAN SERVICES Fragile X Syndrome to Improve Services Emphasis Panel; Loan Repayment Program
and Outcomes, DD15–003, initial (LRP).
National Institutes of Health review. Date: April 20–24, 2015.
In accordance with Section 10(a)(2) of Time: 8:00 a.m. to 5:00 p.m.
National Institute of Neurological the Federal Advisory Committee Act Agenda: To review and evaluate grant
Disorders and Stroke; Notice of Closed (Pub. L. 92–463), the Centers for Disease applications.
Meeting Place: National Institutes of Health, 5601
Control and Prevention (CDC) Fishers Lane, Rockville, MD 20892, (Virtual
Pursuant to section 10(d) of the announces the aforementioned meeting: Meeting).
Federal Advisory Committee Act, as Time and Date: 10:00 a.m.–6:00 p.m., April Contact Person: Maryam Feili-Hariri,
amended (5 U.S.C. App.), notice is 14, 2015 (Closed). Ph.D., Scientific Review Officer, Scientific
hereby given of the following meeting. Place: Teleconference. Review Program, Division of Extramural
The meeting will be closed to the Status: The meeting will be closed to the Activities, National Institutes of Health/
public in accordance with the public in accordance with provisions set NIAID, 5601 Fishers Lane, Rockville, MD
provisions set forth in sections forth in Section 552b(c)(4) and (6), Title 5 20852, 240–669–5026, haririmf@
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., U.S.C., and the Determination of the Director, niaid.nih.gov.
as amended. The grant applications and Management Analysis and Services Office, Name of Committee: National Institute of
CDC, pursuant to Public Law 92–463. Allergy and Infectious Diseases, Special
the discussions could disclose Matters for Discussion: The meeting will Emphasis Panel; NIAID Investigator Initiated
confidential trade secrets or commercial include the initial review, discussion, and Program Project Applications (P01).
property such as patentable material, evaluation of applications received in Date: April 20, 2015.
and personal information concerning response to ‘‘Using Longitudinal Data to Time: 1:00 p.m. to 5:00 p.m.
individuals associated with the grant Characterize the Natural History of Fragile X Agenda: To review and evaluate grant
applications, the disclosure of which Syndrome to Improve Services and applications.
would constitute a clearly unwarranted Outcomes, DD15–003, initial review.’’ Place: National Institutes of Health, Room
invasion of personal privacy. Contact Person for More Information: M. 3F100, 5601 Fishers Lane, Rockville, MD
Chris Langub, Ph.D., Scientific Review 20852, (Telephone Conference Call).
Name of Committee: National Institute of Officer, CDC, 4770 Buford Highway NE., Contact Person: Jane K. Battles, Ph.D.,
Neurological Disorders and Stroke Special Mailstop F–80, Atlanta, Georgia 30341, Scientific Review Officer, Scientific Review
Emphasis Panel; Epilepsy Clinical Trial Telephone: (770) 488–3585, EEO6@cdc.gov. Program DEA/NIAID/NIH/DHHS, 5601
Review. The Director, Management Analysis and Fishers Lane, Rockville, MD 20852, 240–669–
Date: April 22, 2015. Services Office, has been delegated the 5029, battlesja@mail.nih.gov.
Time: 12:00 p.m. to 5:00 p.m. authority to sign Federal Register notices
Agenda: To review and evaluate grant Name of Committee: National Institute of
pertaining to announcements of meetings and Allergy and Infectious Diseases, Special
applications. other committee management activities, for
Place: National Institutes of Health, Emphasis Panel; NIAID Peer Review Meeting.
both the Centers for Disease Control and Date: April 23, 2015.
Neuroscience Center, 6001 Executive
Prevention and the Agency for Toxic Time: 1:00 p.m. to 4:00 p.m.
Boulevard, Rockville, MD 20852, (Telephone
rljohnson on DSK3VPTVN1PROD with NOTICES

Substances and Disease Registry. Agenda: To review and evaluate contract
Conference Call).
Contact Person: William C. Benzing, Ph.D., Catherine Ramadei, proposals.
Scientific Review Officer, Scientific Review Place: National Institutes of Health, 5601
Acting Director, Management Analysis and Fishers Lane, Rockville, MD 20852,
Branch, Division of Extramural Research,
Services Office Centers for Disease Control (Telephone Conference Call).
NINDS/NIH/DHHS/Neuroscience Center,
and Prevention. Contact Person: Betty Poon, Ph.D.,
6001 Executive Boulevard, Suite 3208, MSC
9529, Bethesda, MD 20892–9529, 301–496– [FR Doc. 2015–06849 Filed 3–24–15; 8:45 am] Scientific Review Officer, Scientific Review
0660, benzingw@mail.nih.gov. BILLING CODE 4163–18–P Program, Division of Extramural Activities,

VerDate Sep<11>2014 15:26 Mar 24, 2015 Jkt 235001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\25MRN1.SGM 25MRN1

Document Created: 2018-02-21 09:49:03
Document Modified: 2018-02-21 09:49:03

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		10:00 a.m.-6:00 p.m., April 14, 2015 (Closed).
FR Citation		80 FR 15798

80 FR 15798 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 57 (March 25, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention